Reporting to the Executive Director, Global Marketing, the Senior Product Manager, US Commercial plays a key role in tactical implementation of the potential launch of MOLBREEVI*TM (molgramostim inhalation solution), an investigational therapy for treating autoimmune pulmonary alveolar proteinosis (aPAP).
This role is critical in guiding the development and implementation of the US Brand Plan to ensure a successful market introduction. The position focuses on executing innovative and impactful initiatives for healthcare professionals (HCPs) and patients, managing the marketing mix, and collaborating cross-functionally with various departments to meet brand and company objectives.
Responsibilities- Under the guidance of the Executive Director, Global Marketing, assist in developing the strategic US brand plan for MOLBREEVI, including market opportunity identification, market-shaping, positioning, messaging, campaign development, and segmentation
- Optimize Disease State Awareness campaigns to increase market impact
- Collaborate with opinion leaders and cross-functional teams to develop and gain approval for core promotional programs and tactics, ensuring launch readiness
- Lead commercial execution at key conferences, society meetings, and educational initiatives
- Contribute to the design and development of exceptional patient services and specialty pharmacy programs
- Create and implement marketing and sales training materials
- Develop and execute print, digital, and social media tactics for both HCPs and patients
- Serve as a brand expert with deep knowledge of disease state, treatment landscape, patient journey, and market trends
- Oversee partners to ensure strategic alignment and timely, budget-compliant execution of programs and tactics
- Ensure all Medical Legal Regulatory (MLR) review processes are followed, and all programs are compliant with legal guidance and corporate policies
- Serve as the primary coordinator for Medical, Legal, and Regulatory (MLR) review, managing workflows and timelines while partnering with cross-functional teams to ensure all materials and programs meet legal, regulatory, and corporate compliance standards.
- Manage funds and resources efficiently and with an entrepreneurial approach
- Other duties and projects as assigned.
Required Qualifications- Bachelor's degree required
- 5+ years pharma/biotech industry experience required
- HCP and/or patient marketing experience required
- Commercial launch experience required; rare disease commercial launch experience strongly preferred
- Demonstrated experience in driving performance and fostering collaboration
- Ability to embrace teamwork and project management within a collaborative environment
- Demonstrated analytical skills with regards to market research and key business insights
- Strong interpersonal and communication skills and the ability to effectively drive performance
- Excellent written and verbal communication skills in English
- Ability to move nimbly between strategic thinking and tactical details to execute with excellence
- Ability to thrive in a fast-paced, entrepreneurial environment.
- Experience in managing external partners (e.g., consultants, vendors, agencies, etc.)
- Proven ability to develop exceptional relationships and have an impact on others
- Experience working in a start-up and/or mid-cap sized company highly desired
Location and Travel- This role is remote within the US and requires availability to work US Eastern Time Zone.
- Occasional travel may be required to the Yardley office, conferences, or other events, up to 25% of the time.
Savara provides comprehensive benefits including:- Highly competitive medical, dental, and vision coverage
- Flexible Spending Accounts for health care and dependent care expenses
- Paid time off and paid holidays, including Dec 24-Jan 1
- Paid parental leave
- 401k with highly competitive match
- Life, AD&D, STD and LTD insurance coverage
Savara's compensation can include an hourly rate, bonus, and equity. The salary range for this role is $135,000 to $155,000.
*MOLBREEVI is the proposed trade name for molgramostim inhalation solution. It is not approved in any indication. MOLBREEVI is a trademark of Savara Inc.
#LI-Remote
